logo

For the Inventor, By the Inventor

Saulon Larue, France

Francois Bellamy

This inventor holds 13 USPTO granted patents, plus 3 CIPO patents, primarily in Therapeutic Agents. Top assignees: Fournier Innovation Et Synergie, Fournier Industrie Et Sante, Centre National De La Recherche Scientifique. Active years: 1985-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francois Bellamy. Retrieved from https://idiyas.com/inventor/francois-bellamy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13

% Patents Active = 100.0


Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Saulon la Chapelle, FR (1989 - 1993)
  • Saulon-La-Rue, FR (1985 - 2020)

Company Filing History:

goldMedal4 out of 7 
 
Fournier Innovation Et Synergie
 patents
silverMedal3 out of 20 
 
Fournier Industrie Et Sante
 patents
bronzeMedal1 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
4. 1 out of 7 
 
Enterome
 patents
5. 1 out of 1 
 
Institut De Recherches Chimiques Et Al
 patent
6. 1 out of 1 
 
Societe De Recherches Industrielle S.o.r.i.
 patent
7. 1 out of 13 
 
Societe De Recherches Industrielles Sori
 patents
8. 1 out of 1 
 
Societe De Recherches Industries (s.o.r.i.)
 patent
9. 1 out of 1 
 
Societe De Recheres Industrielles
 patent
10. 1 out of 156 
 
The University of Nantes
 patents
11. 1 out of 25 
 
Université Clermont Auvergne
 patents
where one patent can have more than one assignee

Years Active: 1985-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Mannose Derivatives
Thioxylosides
Therapeutic Agents
Asymmetrical Esters
Dihydropyridine
Benzopyranone
Piperidine Derivatives
Benzylphenyl Osides
Impotence Treatment
Novel Compounds
13 patents (USPTO):Explore Patents
1. 10543223 - Mannose derivatives useful for treating pathologies associated with adherent (2020-01-28),
2. 5451609 - Treatment of impotence (1995-09-19),
3. 5246961 - .beta.-d-phenylthioxylosides, and their use as therapeutic agents (1993-09-21),
4. 5169838 - Benzopyranone-.beta.-D-thioxylosides and their use in therapy (1992-12-08),
5. 5101048 - .beta.-D-phenylthioxylosides, their method of preparation and their use (1992-03-31),
6. 4996347 - Novel beta-d-phenylthioxylosides, their method of preparation and their (1991-02-26),
7. 4960758 - Novel .beta.-D-phenylthioxylosides, their method of preparation and (1990-10-02),
8. 4900833 - Asymmetrical ester derivatives of 1,4-dihydropyridine-3,5-dicarboxylic (1990-02-13),
9. 4877808 - Novel .beta.-D-phenylthioxylosides, their method of preparation and (1989-10-31),
10. 4806544 - Asymmetrical ester derivatives of 1,4-dihydrophyridine-3,5-dicarboxylic (1989-02-21),
11. 4680402 - Benzoyl-phenyl-piperidine derivatives (1987-07-14),
12. 4598068 - Benzylphenyl osides, method of preparation and use therefor (1986-07-01),
13. 4528294 - Benzoyl-phenyl-piperidine derivatives (1985-07-09),

Title: The Innovative Contributions of Francois Bellamy

Introduction

Francois Bellamy is a notable inventor based in Saulon Larue, France. He has made significant contributions to the field of medicine, particularly through his innovative patents. With a total of 13 patents to his name, Bellamy has focused on developing solutions for various health-related issues.

Latest Patents

Among his latest patents, Bellamy has developed mannose derivatives that are useful for treating pathologies associated with adherent cells. These derivatives are particularly effective in addressing inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. They also target urinary tract infections, including painful bladder syndrome and interstitial cystitis. Additionally, his work extends to metabolic diseases like obesity and diabetes, autoimmune inflammatory diseases, and colorectal cancer, specifically colon cancer. Another significant invention by Bellamy is a novel anti-impotence composition. This invention involves administering deacetyl moxisylyte or its non-toxic salts in a ready-to-use aqueous solution via injection, effectively inducing a rigid penile erection.

Career Highlights

Francois Bellamy has worked with several prominent companies throughout his career. Notably, he has been associated with Fournier Innovation et Synergie and Fournier Industrie et Santé. His work in these organizations has allowed him to further his research and development efforts in the medical field.

Collaborations

Bellamy has collaborated with various professionals in his field, including Soth Samreth and Jean Millet. These collaborations have contributed to the advancement of his innovative projects and patents.

Conclusion

Francois Bellamy's contributions to medical innovation through his patents demonstrate his commitment to improving health outcomes. His work continues to impact the fields of medicine and healthcare significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…